Concepedia

Jian Xu

JX

11

Publications

447

Citations

11

H-Index

1997

Active since

Affiliations

Zhejiang University(Current)

Zhejiang Cancer Hospital

Zhejiang Lab

First Affiliated Hospital Zhejiang University

University of Houston

Jian Xu is an author at Zhejiang University specializing in oncology, biostatistics, and statistics.

ORCID

Top concepts

Publications per year

1997–2024

11

Publications

11

NEK2 inhibition triggers anti-pancreatic cancer immunity by targeting PD-L1

Xiaozhen Zhang, Xing Huang, Jian Xu et al. · Nature Communications · 2021 · 109 citations · Full text

Targeting ubiquitin-specific protease 8 sensitizes anti-programmed death-ligand 1 immunotherapy of pancreatic cancer

Hanshen Yang, Xiaozhen Zhang, Mengyi Lao et al. · Cell Death and Differentiation · 2022 · 76 citations · Full text

Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors

Xiaozhen Zhang, Mengyi Lao, Jian Xu et al. · Journal for ImmunoTherapy of Cancer · 2022 · 70 citations · Full text

Targeting cancer-associated fibroblast autophagy renders pancreatic cancer eradicable with immunochemotherapy by inhibiting adaptive immune resistance

Xiaozhen Zhang, Mengyi Lao, Hanshen Yang et al. · Autophagy · 2024 · 53 citations · Full text

Targeting MFAP5 in cancer-associated fibroblasts sensitizes pancreatic cancer to PD-L1-based immunochemotherapy via remodeling the matrix

Yi Duan, Xiaozhen Zhang, Honggang Ying et al. · Oncogene · 2023 · 45 citations · Full text

Rows per page

1–5 of 11